QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
OTCMKTS:INNV

InnovAge - INNV Stock Forecast, Price & News

$7.63
+0.05 (+0.66%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$7.24
$7.89
50-Day Range
$6.26
$7.69
52-Week Range
$3.39
$8.03
Volume
52,440 shs
Average Volume
41,030 shs
Market Capitalization
$1.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.98

InnovAge MarketRank™ Forecast

Analyst Rating
Hold
1.75 Rating Score
Upside/​Downside
21.6% Downside
$5.98 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.56mentions of InnovAge in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.33) to ($0.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.87 out of 5 stars


INNV stock logo

About InnovAge (OTCMKTS:INNV) Stock

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. As of June 30, 2022, it served approximately 6,650 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Initiating recovery mode
Tuesday 9/20 Insider Buying Report: SPOK, INNV
See More Headlines
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Company Calendar

Last Earnings
11/08/2022
Today
1/27/2023
Next Earnings (Estimated)
2/07/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INNV
Previous Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.98
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$3.90
Forecasted Upside/Downside
-21.6%
Consensus Rating
Hold
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

Net Income
$-6,520,000.00
Pretax Margin
-5.03%

Debt

Sales & Book Value

Annual Sales
$698.64 million
Cash Flow
$0.09 per share
Book Value
$2.50 per share

Miscellaneous

Free Float
135,231,000
Market Cap
$1.03 billion
Optionable
Not Optionable
Beta
-0.06

Key Executives

  • Mr. Patrick Blair (Age 52)
    Pres & CEO
    Comp: $1.48M
  • Ms. Barbara K. Gutierrez CPA (Age 60)
    Chief Financial Officer
    Comp: $625.45k
  • Ms. Nicole D'Amato (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $683.95k
  • Mr. Edward Moore Kennedy Jr. (Age 62)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 72)
    R.N., Independent Director
    Comp: $120k
  • Ms. Maria Lozzano (Age 43)
    Chief Operating Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer
  • Ms. Robin Doerr (Age 59)
    Chief Sales & Marketing Officer
  • Mr. Rob Borella
    Chief Sales & Marketing Officer













INNV Stock - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last year. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings
or view top-rated stocks.

What is InnovAge's stock price forecast for 2023?

4 Wall Street analysts have issued 12 month target prices for InnovAge's shares. Their INNV share price forecasts range from $3.90 to $8.00. On average, they anticipate the company's share price to reach $5.98 in the next year. This suggests that the stock has a possible downside of 21.1%.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2023?

InnovAge's stock was trading at $7.18 on January 1st, 2023. Since then, INNV stock has increased by 5.6% and is now trading at $7.58.
View the best growth stocks for 2023 here
.

When is InnovAge's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023.
View our INNV earnings forecast
.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) announced its quarterly earnings results on Tuesday, November, 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The company earned $171.22 million during the quarter, compared to analyst estimates of $173.04 million. InnovAge had a negative trailing twelve-month return on equity of 6.79% and a negative net margin of 3.92%.

What other stocks do shareholders of InnovAge own?
What is InnovAge's stock symbol?

InnovAge trades on the OTCMKTS under the ticker symbol "INNV."

Who are InnovAge's major shareholders?

InnovAge's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Strs Ohio (0.05%). Insiders that own company stock include Edward Moore Jr Kennedy, Maureen Hewitt and Thomas Scully.
View institutional ownership trends
.

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InnovAge's stock price today?

One share of INNV stock can currently be purchased for approximately $7.58.

How much money does InnovAge make?

InnovAge (OTCMKTS:INNV) has a market capitalization of $1.03 billion and generates $698.64 million in revenue each year. The company earns $-6,520,000.00 in net income (profit) each year or ($0.20) on an earnings per share basis.

How many employees does InnovAge have?

The company employs 2,000 workers across the globe.

How can I contact InnovAge?

InnovAge's mailing address is 8845 Rehco Road, San Diego CA, 92121. The official website for the company is www.innovuspharma.com. The company can be reached via phone at 844-803-8745 or via email at ir@innovuspharma.com.

This page (OTCMKTS:INNV) was last updated on 1/27/2023 by MarketBeat.com Staff